Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin added to sodium valproate for migraine prophylaxis
IRCT20180106038242N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in migraine with aura comparing Sodium valproate + atorvastatin with Sodium valproate + placebo (2 arms). Primary endpoints: Number of attacks, Severity of attacks and 1 more. Started Dec 2017; status: completed.
02
Drugs
atorvastatinvalproic acid
03
Conditions
migraine with aura
Beyond the preview
Go deeper on IRCT20180106038242N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180106038242N1.